Luka de Vos-Hillebrand - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Frontiers in Immunology|December 25, 2023

Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case reportSimon Fietz, Anne Fröhlich, Cornelia Mauch, et al.

Frontiers in Immunology|April 4, 2024

Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case reportTanja Fetter, Simon Fietz, Maya Bertlich, et al.

Pigment Cell & Melanoma Research|November 17, 2023

CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanomaLuka de Vos-Hillebrand, Simon Fietz, Philip Hillebrand, et al.

Medrxiv : the Preprint Server for Health Sciences|February 6, 2026

Comparative Performance of agentic AI and Physicians in Taking Clinical History across Leading Large Language Models (LLMs)Sophie Steinbuch, Luka de Vos-Hillebrand, Connor O'Neill-Dee, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Frontiers in Immunology|December 25, 2023

Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case reportSimon Fietz, Anne Fröhlich, Cornelia Mauch, et al.

Frontiers in Immunology|April 4, 2024

Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case reportTanja Fetter, Simon Fietz, Maya Bertlich, et al.

Pigment Cell & Melanoma Research|November 17, 2023

CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanomaLuka de Vos-Hillebrand, Simon Fietz, Philip Hillebrand, et al.

Medrxiv : the Preprint Server for Health Sciences|February 6, 2026

Comparative Performance of agentic AI and Physicians in Taking Clinical History across Leading Large Language Models (LLMs)Sophie Steinbuch, Luka de Vos-Hillebrand, Connor O'Neill-Dee, et al.

Pageof 1